OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine
Janet H. Ford, Tobias Kurth, Amaal J. Starling, et al.
Headache The Journal of Head and Face Pain (2020) Vol. 60, Iss. 10, pp. 2304-2319
Open Access | Times Cited: 9

Showing 9 citing articles:

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
Sait Ashina, Agustín Melo-Carrillo, Ajayi Toluwanimi, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 23

Setting higher standards for migraine prevention: A position statement of the International Headache Society
Simona Sacco, Messoud Ashina, Hans‐Christoph Diener, et al.
Cephalalgia (2025) Vol. 45, Iss. 2
Closed Access | Times Cited: 1

Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics
Kofi Frimpong-Manson, Yuma T. Ortiz, Lance Richard McMahon, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 8

In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study
Alicia Alpuente, Victor J Gallardo, Edoardo Caronna, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 30

Rates of Response to Atogepant for Migraine Prophylaxis Among Adults
Richard B. Lipton, Patricia Pozo‐Rosich, Andrew Blumenfeld, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2215499-e2215499
Open Access | Times Cited: 13

Treatment satisfaction with calcitonin gene‐related peptide monoclonal antibodies as a new patient‐reported outcome measure: A real‐life experience in migraine
A. López-Bravo, Antonio Oliveros‐Cid, Laura Sevillano‐Orte
Acta Neurologica Scandinavica (2022) Vol. 145, Iss. 6, pp. 669-675
Open Access | Times Cited: 12

Erenumab versus topiramate: migraine‐related disability, impact and health‐related quality of life
Uwe Reuter, Axel Heinze, Astrid Gendolla, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 12
Open Access | Times Cited: 1

Erratum

Headache The Journal of Head and Face Pain (2021) Vol. 61, Iss. 6, pp. 977-977
Open Access

Page 1

Scroll to top